Oligodeoxynucleotides covalently linked to an acridine derivative were targeted to part of the 3'-terminal sequence which is common to the eight RNAs of type A influenza viruses. The cytopathic effect of the virus on MDCK cells in culture was strongly decreased by a heptanucleotide covalently attached to the acridine ring. Control experiments using other oligonucleotide sequences showed that the effect was specific for the complementary sequence of the 3'-terminal region of the viral RNAs. The RNA transcriptase reaction of a type A virus was also selectively inhibited in vitro by the heptanucleotideacridine conjugate. A type B influenza virus was used as a control. The common sequence at the 3' end of its eight viral RNAs is different from that of type A viruses. Three mismatches were expected with the heptanucleotide which was fully complementary to type A viral RNAs. This heptanucleotide had no effect on the cytopathic effect of a type B influenza virus. These results demonstrate that viral RNAs are specific targets for the oligonucleotide-acridine conjugate that inhibits the cytopathic effect of type A influenza viruses.
INTRODUCTION
Selective antiviral agents usually exploit differences existing between virus and host cell enzymes ( 1 ). Another strategy to achieve selectivity in antiviral chemotherapy would be to use oligonucleotides specifically designed to interact with only viral nucleic acid sequences. The possibility of using oligodeoxynucleotides to block gene expression has previously received experimental support (2-7). Oligonucleotides targeted to messenger RNAs can inhibit translation (3) (4) (5) . when targeted to viral RNAs they may block viral development (2,3f6,7) . influenza viruses have a segmented genome consisting of eight single-stranded negative-sense RNA molecules which code for the different viral proteins (8, 9) . These eight RNAs have common sequences at their 3' and 5' ends. The 3'-terminal sequences of the eight viral RNAs of type A viruses are identical over twelve nucleotides except for a C/U degeneracy at the fourth position (8, 10) . T n i S 3'-terminal sequence constitute a potential target for oligonucleotides which could be used as specific antiviral agents. This approach has been followed by Stridth et al. attempt to selectively inhibit the influenza virus RNA transcriptase. However negative results were reported.
We have recently described the synthesis of a new family of molecules in which an oligodeoxynucleotide is covalently linked via its 3'-phosphate to an intercalating agent, namely, 2-methoxy, 6-chloro, 9-amino-acridine (12) (13) (14) . yyie oligonucleotide retains its binding specificity towards the complementary sequence. The intercalating agent provides an additional binding energy due to its insertion between the base pairs formed by the oligonucleotide with its complementary sequence. These composite molecules can be used to inhibit messenger R N A translation in cell-free extracts or in microinjected Xenopus oocytes (15, 16) . The acridine derivative facilitates uptake by living cells and protects the oligonucleotide against 3'-exonucleases (unpublished results). Because of these promising characteristics we attempted to use such oligonucleotide-acridine conjugates to inhibit the multiplication of influenza viruses in cell cultures. Here we show that an oligonucleotide covalently linked to an acridine derivative and targeted to part of the 3'-terminal common sequence of type A viruses inhibits the cytopathic effect of these viruses on M D C K cells in culture. The 3'-terminal sequence of type B influenza viruses differ from that of type A viruses at four positions. Due to the presence of mismatches the oligonucleotide that inhibits the cytopathic effect of type A viruses has no effect on a type B virus.
MATERIALS AND METHODS

Antiviral studies
The a n t i v i r a l effect of oligodeoxynucleotide-acridine conjugates was based on the inhibition of the cytopathic effect (CPE) of different s t r a i n s of influenza virus on MDCK cells in culture. MDCK c e l l s were grown in minimal Eagle's medium-Earle's s a l t s (MEM) supplemented with 5 % fetal calf serum, p e n i c i l l i n and streptomycin sulfate at 10 I.U. and 40 yg/ml, respectively. To confluent c e l l monolayers in 24 well-Falcon plates were added 0.85 ml of MEM medium (without serum but supplemented with 5 ug/ml trypsin and a n t i b i o t i c s as above) and 50 yl of investigated compound (concentrated 20 X). Cultures were then infected with 0.1 ml of virus (containing 20 x TCID 50) and incubated for three days a t 37°C in a 5 $ CO2 atmosphere. Cultures were then examined under the microscope to assess the degree of the cytopathic effect (17) . in some instances inhibition of the cytopathic effect was visualized by fixing and staining the remaining monolayer with formaldehyde (15 %) and crystal violet (0,1 %).
RNA transcrlptase assays
Influenza virus A/Philippines/2/82 , grown in eggs, was kindly provided by Institut Merieux. The virus was purified on sucrose gradient as described < 1 8 ) , except that the RNAse step was omitted. Aliquots (180000 u HA/ml)
were stored frozen at -70°C. RNA transcriptase activity was measured at 31°C
according to Plotch and Krug 0 9), using 3H-UTP (H00 cpm/pmole) as labelled 
RESULTS
Inhibition of the cytopathlc effect of type A influenza viruses
Three oligonucleotides used in t h i s study were complementary to part of the 12 nucleotide-long 3'-terminal sequence of influenza viruses of type A ( Figure 1 ). Since influenza virus is a negative-strand virus, oligonucleotides complementary to messenger RNAs were also synthesised. They were directed against the 5'-end of mRNAs in the region which is complementary to the common 12-nucleotide sequence at the 3'-end of v i r a l RNAs. Experiments were carried out using MDCK c e l l s in c u l t u r e . Three s t r a i n s of type A influenza viruses were used to infect c e l l s : A/Puerto Rico (A/PR/8/3I), A/Victoria/3/75, A/Philippines/2/82. Oligonucleotides covalently linked to the acridlne derivative were added at the time of infection. Their effect on virus multiplication was assayed after different times of incubation by scoring under the microscope the extent of the cytopathic effect (CPE).
As shown in Table 1 , two undecanucleotide-acridine conjugates (compounds [1] and [2] ), complementary to nucleotides 1-11 of v i r a l RNAs were found inactive against A/Victoria/3/75 virus multiplication. These two compounds differed by one base to take Into account the C/U degeneracy a t the In contrast, the heptanucleotide-acridine conjugate [3] complementary to region 5-11 of the viral RNAs strongly reduced the cytopathic effect of all three strains of type A Influenza virus (Table 1) . Complete inhibition of virus multiplication was observed at concentrations higher than 50 uM. The same oligonucleotide without the covalently attached acridine had no effect (not shown). The results presented in Table 1 show that the acridine deriva- Since the acridine derivative alone had no effect on the cytopathic effect of the virus at sub-toxic concentrations, it appears that the mere release of acridine from a small fraction of the oligonucleotlde-acrldlne conjugate was not the source of the antl-cytopathic effect. This conclusion is also supported by the observation that no antiviral activity was detected with the oligonucleotide-acridine derivatives [ t ] , [5] , and [6] directed TABLE 1 Effect of oligonucleotide-acridlne conjugates and AcrmgOH on the Inhibition of Influenza virus multiplication In c e l l c u l t u r e s . cleotide-acridine conjugate protects MDCK c e l l s against type A virus infection whereas i t has no effect On type B v i r u s . These experiments led us to the conclusion that the oligonucleotide-acridine conjugate dCAAAGAAOn^Acr exerted i t s anti-cytopathic effect by hybridizing to the viral RNAs.
In vitro transcription of viral RNAs
Influenza v i r a l RNAs are involved in two processes ( 8 , 9 ) , They are copied by the RNA transcriptase either into full length complementary plusstrands or into mRNAs u t i l i z i n g the capped 5'-terminal region of an endogenous mRNA as primer. Influenza virions can be disrupted in vitro and release v i r a l RNAs with the different subunits of RNA-dependent RNA polymerase bound to the 3'-end of v i r a l RNAs ( 2 1 ) . When supplemented with a primer (such as ApG), the four ribonucleoside-triphosphates and Mg ++ , virion lysates provide an in vitro system to assess the RNA transcriptase reaction ( 2 1 ) .
As shown in Figure 3 , compound [3J inhibited the enzymatic reaction by 70 % at 30 pM. The inhibition, however, did not appreciably increase a t higher concentrations (100 viM).Acrm 5 OH had no effect at 3 yM, a concentration which proved to be highly toxic to c e l l s in culture (Table 1 ) . At 30 uM AcrnujOH inhibited the RNA transcriptase a c t i v i t y by 60 %. However the i n h i b itory effect of compound [3] was not mediated by the acridine moiety since the heptanucleotide-acridine conjugate [6] , which has the same sequence as the v i r a l template, did not inhibit the RNA transcriptase reaction. No effect was observed with the undecanucleotide-acridine conjugates [1] and [2] at 30 uM and 100 uM concentrations. These r e s u l t s suggest that the absence of a n t iv i r a l a c t i v i t y of compounds [1 ] and [2] in c e l l cultures is not related to a lack of intracellular penetration but rather to the lack of a c c e s s i b i l i t y of the very 3'-end of the v i r a l RNAs resulting from binding of the t r a n s c r i p t a s e complex (21),
DISCUSSION
We have shown here that an heptanucleotide covalently linked to an acridine moiety (compound [3] ) and targeted to part of the 3'-terminal sequence common to the eight viral RNAs of type A Influenza viruses, inhibits the multiplication of these viruses in cell cultures. Although the antiviral activity was observed at high concentration (2 50 viM), it appeared nevertheless to be selective. First, no cytotoxiclty was observed at these concentrations. Second, only type A viruses were Inhibited while a type B influenza virus was completely Insensitive to the compound. In type B influenza viruses there is a common twelve nucleotide-long sequence at the 3'-termini with a Due to the presence of mismatches, the oligonucleotide which inhibits the cytopathlc effect of type A viruses has no effect on type B viruses. This result strongly suggests that the 3'-region of the viral RNAs is the target for compound [3] .
Binding of compound [3] to the viral RNAs is expected to affect early events of influenza virus replication. As shown in Figure 3 As compared to compound [3] , the lack of antiviral activity of the undecanucleotide-acridine conjugates (compounds [1 ] and [2] ) was somehow unexpected. Since these compounds were also inactive in vitro in the RNA transcriptase reaction, the absence of inhibition of the cytopathic effect in cell cultures was not likely due to a decreased cell uptake as compared with compound [3] . It is known that the viral transcriptase complex is bound to the Moreover they bind more strongly to ribonuclelc acids than to deoxyribonucleic acids in their single-stranded form (27) . Their evaluation as specific blookers of messenger and viral RNAs is presently under way.
